Continuous positive airway pressure therapy suppresses inflammatory cytokines and improves glucocorticoid responsiveness in patients with obstructive sleep apnea and asthma: A case–control study

Bibliographic Details
Title: Continuous positive airway pressure therapy suppresses inflammatory cytokines and improves glucocorticoid responsiveness in patients with obstructive sleep apnea and asthma: A case–control study
Authors: Bassam Mahboub, Zelal Kharaba, Rakhee K Ramakrishnan, Narjes Saheb Sharif Askari, Laila Ibraheem Salameh, Hassan Saber Alhariri, Mayank G Vats, Wafa Taleb Erabia, Esra'a Mohammad Alshawamreh, Yassen Alfoteih, Andrea K Mogas, Rabih Halwani, Qutayba Hamid
Source: Annals of Thoracic Medicine, Vol 17, Iss 3, Pp 166-172 (2022)
Publisher Information: Wolters Kluwer Medknow Publications, 2022.
Publication Year: 2022
Collection: LCC:Diseases of the circulatory (Cardiovascular) system
LCC:Diseases of the respiratory system
Subject Terms: asthma, continuous positive airway pressure (cpap), cytokines, glucocorticoids, inflammation, inflammatory biomarkers, obstructive sleep apnea, systemic, Diseases of the circulatory (Cardiovascular) system, RC666-701, Diseases of the respiratory system, RC705-779
More Details: CONTEXT: Asthma and obstructive sleep apnea (OSA) are prevalent respiratory disorders that frequently coexist. Continuous positive airway pressure (CPAP) therapy is the standard treatment for OSA. However, its effects on systemic inflammation and glucocorticoid responsiveness in OSA patients with asthma are largely unknown. AIMS: To examine the potential role of CPAP therapy in reducing systemic inflammation and improving glucocorticoid responsiveness in asthmatic patients with OSA. SETTINGS AND DESIGN: A case–control study was conducted at the respiratory and sleep clinics involving patients with OSA and patients with asthma and OSA. METHODS: The levels of inflammatory asthma biomarkers (interleukin [IL]-4, IL-17A, IL-8, IL-2, and interferon-γ [IFN-γ]), and glucocorticoid receptors (GR)-α and GR-β, were determined to compare systemic inflammation and glucocorticoid responsiveness between pre- and post-1-month CPAP treatment in both groups. STATISTICAL ANALYSIS: The Wilcoxon signed-rank test was used to compare inflammatory biomarkers before and after CPAP therapy. P < 0.05 considered statistically significant. The analysis was performed using SPSS. RESULTS: Recruited patients (n = 47), 51% (n = 24) had OSA and 49% (n = 23), had OSA with asthma. Interestingly, the blood levels of IL-17 and IL-8 were significantly decreased post-CPAP therapy in OSA patients, whereas IL-4, IL-17, and IFN-γ were significantly reduced post-CPAP treatment in OSA patients with asthma. Remarkably, CPAP therapy improved glucocorticoid responsiveness in asthmatic patients with OSA, but not in the OSA group and an increase in the GR-α/GR-β ratio was noted post-CPAP therapy. CONCLUSIONS: Continuous positive airway pressure therapy improved responsiveness to glucocorticoid treatment and demonstrated a suppressive effect on proinflammatory cytokines in asthmatics with OSA.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1817-1737
1998-3557
Relation: http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2022;volume=17;issue=3;spage=166;epage=172;aulast=Mahboub; https://doaj.org/toc/1817-1737; https://doaj.org/toc/1998-3557
DOI: 10.4103/atm.atm_37_22
Access URL: https://doaj.org/article/68ad7558731340738c12f6abc303381e
Accession Number: edsdoj.68ad7558731340738c12f6abc303381e
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:18171737
19983557
DOI:10.4103/atm.atm_37_22
Published in:Annals of Thoracic Medicine
Language:English